ZAI LAB (09688) proposed to issue an additional 200 million US dollars worth of American Depositary Shares.
Zhaiding Medicine (09688) announced on November 13, 2024 (Eastern Time in the United States)...
ZAI LAB (09688) announced that on November 13, 2024 (US Eastern time) / November 14, 2024 (Shanghai and Hong Kong time), the company initiated the proposed follow-on offering of American Depositary Shares (each representing ten ordinary shares of the company, with a par value of $0.000006 per share) in the amount of $200 million. All American Depositary Shares will be publicly offered by the company. The company expects to grant the underwriters a 30-day option to purchase additional American Depositary Shares up to 15% of the shares sold in the public offering at the public offering price minus the underwriting discount and commissions. The net proceeds from the offering are intended for general corporate purposes.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


